Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2023

Open Access 01.12.2023 | Correspondence

Mixed small cell neuroendocrine carcinoma and squamous cell carcinoma covered by tubulovillous adenoma in the rectum: a case report and detailed molecular analyses

verfasst von: Fengxia He, Xue He, Menghan Cui, Yan Wang

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2023

Abstract

Background

Previously, only six cases of mixed neuroendocrine-non-neuroendocrine neoplasm (MiNENs) with squamous cell carcinoma (SCC) component have been described in the colorectum, and the molecular landscape of MiNENs is also poorly understood. Herein, we present a unique case in which the SCC developed as a component of a MiNEN in the rectum.

Case presentation

The patient was firstly diagnosed as rectal small cell neuroendocrine carcinoma (SCNEC) covered by tubulovillous adenoma, and then mixed SCNEC and SCC in the same site 6 months later. Representative samples from the three histologic subtypes were then sent for next-generation sequencing (NGS) separately. Multiple liver metastases occurred in the following month after the last surgery. The patient died of ketoacidosis 1 year after initial diagnosis of the tumor.

Conclusion

This is the first report of this exceedingly rare tumor type to include NGS of the 3 separate morphological entities. Our findings may expedite the understanding of combined tumors in the colorectum.
Hinweise
Fengxia He and Xue He contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Neuroendocrine carcinomas (NEC) are highly aggressive tumors with poor clinical outcome, accounting for < 1% of all tumors of the colorectum [1]. Squamous cell carcinomas (SCC), which usually involve the esophagus or anal canal, are even more rare in the colorectum [2]. Tumors consisting of NEC and SCC, which belong to mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs), mostly also occur in above-mentioned organs with original squamous epithelium [3]. Herein, we present a unique case of a patient who was firstly diagnosed as rectal small cell NEC (SCNEC) covered by tubulovillous adenoma, and then mixed SCNEC and SCC in the same site 6 months later, of whom multiple liver metastases developed shortly after the last surgery.

Case presentation

A 71-year-old male patient without relevant pre-existing conditions was admitted to our hospital due to altered bowel habit and hematochezia. Abdomen computed tomography (CT) revealed rectal wall thickening and swollen lymph nodes around the rectum (Fig. 1a). Tumor markers were within normal range. Subsequent colonoscopy showed a 2.0 cm × 3.0 cm irregular uplifted neoplasm in the rectum 3 cm from the anal verge (Fig. 1b). Transanal endoscopic microsurgery (TEM) [4] instead of Miles surgery was then performed at the urging of the patient. Microscopic analysis (Fig. 1c, d) exhibited a tubulovillous adenoma with high-grade dysplasia on the surface, and a component of poorly differentiated SCNEC with typical morphological and immunohistochemical characteristics (positive for synaptophysin and CD56, but negative for chromogranin A) limited to the submucosa. Resection margins were free of tumor cells. No chemotherapy was performed after the surgery.
The patient was hospitalized again with hematochezia 6 months later. Abdomen CT showed an inhomogeneous enhanced mass on the left side of rectum which was more pronounced than before (Fig. 2a). Colonoscopy showed a bulge of 1.5 cm in diameter near the anastomotic stoma. Then, Dixon operation was carried out. Macroscopically (Fig. 2b), the mass had a tan-white to gray cut surface and invaded the perirectal adipose tissue. Microscopically (Fig. 2c–h), a solid and perivascular papillary growth pattern with extensive necrosis was observed. Most areas showed distinct squamous appearance with keratin pearl formation and immunohistochemical expression of p40, but not of synaptophysin. Meanwhile, clusters of tumor cells, which were characterized by scant basophilic cytoplasm and “salt and pepper” chromatin, were positive for synaptophysin but negative for p40. Ki-67 index was ~40% and ~90% for SCC and SCNEC, respectively. All tumor cells exhibited positive expression of β-catenin (cytoplasmic and nuclear) and CDX2. SATB2 was positive in SCNEC but not in SCC. In summary, a mixed SCNEC and SCC of the rectum was diagnosed, and only one regional lymph node metastasis with SCNEC was detected.
CT showed multiple liver metastases in the following month. The patient was discharged from the hospital before his first cycle of chemotherapy (etoposide, oxaliplatin plus bevacizumab) was completed. Poor appetite and elevated serum NSE level were observed during follow-up. The patient died of ketoacidosis 1 year after initial diagnosis of the tumor.

Discussion

Previously, only six cases of MiNENs with SCC component have been described in the colorectum [1, 58], and only one tumor was histologically covered by tubulovillous adenoma like ours [7]. It is currently hypothesized that the adenocarcinoma component and NEC component of mixed adenoneuroendocrine carcinoma (MANEC, a subgroup of MiNEN [3]) arise from either multipotent stem cells or 2 similar but separate precursors. However, the pathogenesis of mixed SCC and NEC is not well-defined. Possible causes for squamous colonic carcinoma are malignant transformation of persistent ectopic embryonal nests of ectodermal cells, chronic inflammation, human papillomavirus, pelvic radiation exposure, etc. [1, 2]. Some authors postulated that the non-neuroendocrine component might give rise to a neuroendocrine component through the trans-differentiation process and then acquire a more aggressive phenotype [9]. Molecular analysis was performed in three of the previous six cases, including next-generation sequencing (NGS) in two cases [1]. Nevertheless, neuroendocrine and squamous components were not micro-dissected separately.
In present case, the representative samples from each histologic subtype were sent for NGS separately. Sequence data were evaluated (Table 1) included point mutations, fragment insertion and deletion, gene fusions/rearrangements, copy number alterations, microsatellite state, and tumor mutation burden (TMB). The tumor harbored multiple alterations in genes that are established drivers of oncogenesis, with APC and TP53 mutations being the most frequently found. Other genes, like KRAS, BRCA1, FBXW7, and RNF43, were also found to be altered. All of these mutations shared in all three lineages, supporting the hypothesis of their common clonal origin. However, there were also alterations exclusively present in one or two of the three components, such as RB1 frameshift mutation in SCC and NEC, high copy number gain of CDK4 in NEC, and KMT2B missense mutation in SCC, suggesting that at some point in the tumorigenic process, distinct morphological entities emerge through the activation of separate genetic programs. In addition, missense mutations of FLT4, MLH3, PDGFRB, and PKHD1, of which the specific significances were unknown, were presented in all three histological types as well. Moreover, TMB was high in SCC but low in NEC and adenoma, and the tumors were devoid of microsatellite instability without exception.
Table 1
Results of next-generation sequencing analysis
Gene
Mutations
Abundance (%)
Adenoma
NEC
SCC
KRAS
c.436G>A (p.A146T)
25.5
28.3
31.7
BRCA1
c.4987-2A>G
45.3
34.2
27.7
CDK4
Copy number amplification
-
CN: 4.6
-
TP53
c.159G>A (p.W53*)
41.6
85.2
79.8
APC
c.3964G>T (p.E1322*)
52.3
94.0
78.3
FBXW7
c.217C>T (p.Q73*)
27.6
47.5
37.3
FBXW7
c.372+1G>A
26.4
44.2
32.4
RB1
c.1963dup (p.Y655Lfs*13)
-
67.3%
71.2%
RNF43
c.131del (p.Q44Rfs*7)
25.5
52.1
53.6
FLT4
c.1426C>T (p.R476W)
28.9
49.6
52.5
KMT2B
c.74G>A (p.R25Q)
-
-
22.7
MLH3
c.484A>G (p.M162V)
49.4
7.3
14.3
PDGFRB
c.886A>T (p.S296C)
22.2
6.2
8.8
PKHD1
c.11006C>T (p.S3669L)
26.3
60.9
53.1
TMB
Mutations/Mbases
6.2
8.2
10.3
Low < 10
Low
Low
High
High ≥10
   
Microsatellite
 
Stable
Stable
Stable
Our case highlights a rare disease, in which a SCC developed as a component of a MiNEN in the colorectum, and this is the first report of this exceedingly rare tumor type to include NGS of the 3 separate morphological entities. TP53, APC, and KRAS mutation may be a “trunk,” as they were presented in all tumor clones and were likely involved in driving the tumorigenic process. Other genetic alterations involved may be potential mediators of the trans-differentiation process. We suppose that the tumor might not have been completely removed at the first TEM operation, and lymph node dissection and postoperative chemotherapy were not performed, thus leading to a rapid relapse. In addition, the stimulation of the original surgery might lead to a squamous cell transformation.
Our findings may expedite the understanding of combined tumors in the colorectum. Further research, especially with regard to divergent differentiation of neuroendocrine- and squamous-related genes, is necessary to fully decode the development of this mixed neoplasm.

Acknowledgements

Not applicable.

Declarations

Not applicable.
Written informed consent was obtained from the patient for publication of this case report and the accompanying images.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Woischke C, Jung P, Jung A, et al. Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity. J Pathol Clin Res. 2021;7(1):75–85.CrossRefPubMed Woischke C, Jung P, Jung A, et al. Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity. J Pathol Clin Res. 2021;7(1):75–85.CrossRefPubMed
2.
Zurück zum Zitat Astaras C, Bornand A, Koessler T. Squamous rectal carcinoma: a rare malignancy, literature review and management recommendations. ESMO Open. 2021;6(4):100180.CrossRefPubMedPubMedCentral Astaras C, Bornand A, Koessler T. Squamous rectal carcinoma: a rare malignancy, literature review and management recommendations. ESMO Open. 2021;6(4):100180.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat WHO Classification of Tumours Editorial Board. WHO Classification of Digestive System Tumours, 5th edition. Lyon: International Agency for Research on Cancer (IARC); 2019. WHO Classification of Tumours Editorial Board. WHO Classification of Digestive System Tumours, 5th edition. Lyon: International Agency for Research on Cancer (IARC); 2019.
5.
Zurück zum Zitat Hassan U, Mozayani B, Wong NA. Primary combined neuroendocrine carcinoma (small-cell type) and squamous cell carcinoma of the colon. Histopathology. 2016;68(5):755–8.CrossRefPubMed Hassan U, Mozayani B, Wong NA. Primary combined neuroendocrine carcinoma (small-cell type) and squamous cell carcinoma of the colon. Histopathology. 2016;68(5):755–8.CrossRefPubMed
6.
Zurück zum Zitat Elkbuli A, Dowd B, McKenney M, et al. Mixed neuroendocrine and squamous cell carcinoma of the colon: a case report and literature review. Int J Surg Case Rep. 2019;60:309–13.CrossRefPubMedPubMedCentral Elkbuli A, Dowd B, McKenney M, et al. Mixed neuroendocrine and squamous cell carcinoma of the colon: a case report and literature review. Int J Surg Case Rep. 2019;60:309–13.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Sato H, Shiota M, Urano M, et al. Mixed neuroendocrine–non-neuroendocrine neoplasm with squamous cell carcinoma covered by tubulovillous adenoma in the rectum. Clin J Gastroenterol. 2021;14(4):1136–41.CrossRefPubMed Sato H, Shiota M, Urano M, et al. Mixed neuroendocrine–non-neuroendocrine neoplasm with squamous cell carcinoma covered by tubulovillous adenoma in the rectum. Clin J Gastroenterol. 2021;14(4):1136–41.CrossRefPubMed
8.
Zurück zum Zitat Vardas K, Papadimitriou G, Chantziara M, et al. Mixed large cell neuroendocrine carcinoma with squamous cell carcinoma of the rectum: report of a rare case and review of the literature. Int J Surg Case Rep. 2013;4(12):1076–9.CrossRefPubMedPubMedCentral Vardas K, Papadimitriou G, Chantziara M, et al. Mixed large cell neuroendocrine carcinoma with squamous cell carcinoma of the rectum: report of a rare case and review of the literature. Int J Surg Case Rep. 2013;4(12):1076–9.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Grossi U, Bonis A, Carrington EV, et al. Mixed adenoneuroendocrine carcinoma (MANEC) of the lower gastrointestinal tract: a systematic review with Bayesian hierarchical survival analysis. Eur J Surg Oncol. 2021;47(11):2893–9.CrossRefPubMed Grossi U, Bonis A, Carrington EV, et al. Mixed adenoneuroendocrine carcinoma (MANEC) of the lower gastrointestinal tract: a systematic review with Bayesian hierarchical survival analysis. Eur J Surg Oncol. 2021;47(11):2893–9.CrossRefPubMed
Metadaten
Titel
Mixed small cell neuroendocrine carcinoma and squamous cell carcinoma covered by tubulovillous adenoma in the rectum: a case report and detailed molecular analyses
verfasst von
Fengxia He
Xue He
Menghan Cui
Yan Wang
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2023
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-023-02954-6

Weitere Artikel der Ausgabe 1/2023

World Journal of Surgical Oncology 1/2023 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.